700 liver transplant patients studied to uncover hidden clot risks

NCT ID NCT06513780

Recruiting now Knowledge-focused Sponsor: Ru-zhou Cai Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This observational study follows 700 adult liver transplant recipients to understand how portal vein thrombosis (a blood clot in the liver's main vein) impacts their recovery and long-term health. Researchers will compare those with and without the clot to identify risk factors and build a prediction tool. No treatment or intervention is given—this is purely to gather knowledge.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors better predict and manage complications like portal vein thrombosis after liver transplant, improving patient care.
What could go wrong: This is an observational study, not a treatment trial. It cannot prove cause and effect, and results may not apply to all transplant patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PORTAL VEIN THROMBOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

portal vein thrombosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PORTAL VEIN THROMBOSIS

Contacts and locations

Locations

Beijing Friendship Hospital, Capital Medical University
RECRUITING

Beijing, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.